Please assess the completion status of the following clinical trial:

Trial Title: Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Women ages 18 and older undergoing elective surgical abortion at 5 and 0/7 to 11 and 6/7 weeks gestational age~* Use of IV sedation for pain management~* English or Spanish speaking~* Ability to give informed consent~Exclusion criteria:~* Any pre-operative use of misoprostol (typically given at 12 weeks and above in this clinic)~* Allergy to study medications: lidocaine, midazolam, fentanyl~* Known uterine anomaly~* Prior cervical surgery.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Active Comparator (Type: EXPERIMENTAL): Drug: vaginal 2% Xylocaine
- standard lidocaine paracervical block (Type: OTHER): standard lidocaine paracervical block

Based on this trial design, predict the completion outcome and termination type (if applicable).